170 related articles for article (PubMed ID: 17716427)
1. Searching for a threshold - Not so NICE..
Mooney G; Coast J; Jan S; ; Ryan M; Wiseman V
J Health Serv Res Policy; 2007 Jul; 12(3):190; author reply 190-1. PubMed ID: 17716427
[No Abstract] [Full Text] [Related]
2. On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales.
Birch S; Gafni A
Health Econ; 2002 Apr; 11(3):185-91. PubMed ID: 11921316
[No Abstract] [Full Text] [Related]
3. Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion.
Claxton K; Sculpher M; Culyer A; McCabe C; Briggs A; Akehurst R; Buxton M; Brazier J
Health Econ; 2006 Jan; 15(1):1-4. PubMed ID: 16365910
[TBL] [Abstract][Full Text] [Related]
4. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
Bryan S; Williams I; McIver S
Health Econ; 2007 Feb; 16(2):179-93. PubMed ID: 16960851
[TBL] [Abstract][Full Text] [Related]
5. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
Williams I; Bryan S; McIver S
J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
[TBL] [Abstract][Full Text] [Related]
6. Handling uncertainty in economic evaluations of healthcare interventions.
Briggs AH; Gray AM
BMJ; 1999 Sep; 319(7210):635-8. PubMed ID: 10473486
[No Abstract] [Full Text] [Related]
7. Quality, innovation, and value for money: NICE and the British National Health Service.
Pearson SD; Rawlins MD
JAMA; 2005 Nov; 294(20):2618-22. PubMed ID: 16304076
[TBL] [Abstract][Full Text] [Related]
8. NICE discrimination.
Rawlins M; Dillon A
J Med Ethics; 2005 Dec; 31(12):683-4; discussion 685-8. PubMed ID: 16319226
[No Abstract] [Full Text] [Related]
9. NICE and new: appraising innovation.
Ferner RE; Hughes DA; Aronson JK
BMJ; 2010 Jan; 340():b5493. PubMed ID: 20051468
[No Abstract] [Full Text] [Related]
10. Technology assessment in the German context.
Drummond M
Eur J Health Econ; 2007 Sep; 8 Suppl 1():S3. PubMed ID: 17619919
[No Abstract] [Full Text] [Related]
11. Economic evaluation: an introduction.
Raftery J
BMJ; 1998 Mar; 316(7136):1013-4. PubMed ID: 9550969
[No Abstract] [Full Text] [Related]
12. Patients' views of explicit rationing: what are the implications for health service decision-making?
Devlin N; Appleby J; Parkin D
J Health Serv Res Policy; 2003 Jul; 8(3):183-6. PubMed ID: 12869346
[TBL] [Abstract][Full Text] [Related]
13. Considering the value associated with innovation in health technology appraisal decisions (deliberations): a NICE thing to do?
Green C
Appl Health Econ Health Policy; 2010; 8(1):1-5. PubMed ID: 20038189
[No Abstract] [Full Text] [Related]
14. Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA.
Goldman D; Lakdawalla D; Philipson TJ; Yin W
Health Econ; 2010 Oct; 19(10):1109-16. PubMed ID: 20842680
[No Abstract] [Full Text] [Related]
15. Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal.
Morton A; Adler AI; Bell D; Briggs A; Brouwer W; Claxton K; Craig N; Fischer A; McGregor P; van Baal P
Health Econ; 2016 Aug; 25(8):933-8. PubMed ID: 27374115
[TBL] [Abstract][Full Text] [Related]
16. Prioritizing health technologies in a Primary Care Trust.
Wilson E; Sussex J; Macleod C; Fordham R
J Health Serv Res Policy; 2007 Apr; 12(2):80-5. PubMed ID: 17407656
[TBL] [Abstract][Full Text] [Related]
17. NICE Guide to the Methods of Technology Appraisal: pharmaceutical industry perspective.
Earnshaw J; Lewis G
Pharmacoeconomics; 2008; 26(9):725-7. PubMed ID: 18767892
[No Abstract] [Full Text] [Related]
18. A little learning: reflections on 10 years of NICE technology appraisals.
Longson CM
Health Econ; 2012 Jan; 21(1):30-2. PubMed ID: 22147626
[No Abstract] [Full Text] [Related]
19. Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme.
Henry DA; Hill SR; Harris A
JAMA; 2005 Nov; 294(20):2630-2. PubMed ID: 16304078
[No Abstract] [Full Text] [Related]
20. Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients?
Claxton K; Sculpher M; Palmer S; Culyer AJ
Health Econ; 2015 Jan; 24(1):1-7. PubMed ID: 25488707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
